tetano
Editor, Senior Moderator
J Nephrol. 2017 May 20. doi: 10.1007/s40620-017-0407-9. [Epub ahead of print]
[h=1]Influenza and the patient with end-stage renal disease.[/h] Bowman BT[SUP]1[/SUP], Rosner MH[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza is a commonly encountered and serious pathogen. Patients with end-stage renal disease are more susceptible to serious morbidity and mortality associated with influenza infection. Proper management of patients includes: vaccination, monitoring for symptoms and isolation of potentially infected patients as well as appropriate antiviral therapies. In some cases of exposure, chemoprophylaxis is warranted. Vaccination and appropriate therapies are associated with improved outcomes.
[h=4]KEYWORDS:[/h] Chemoprophylaxis; End-stage renal disease; Influenza; Vaccination
PMID: 28528400 DOI: 10.1007/s40620-017-0407-9
[h=1]Influenza and the patient with end-stage renal disease.[/h] Bowman BT[SUP]1[/SUP], Rosner MH[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza is a commonly encountered and serious pathogen. Patients with end-stage renal disease are more susceptible to serious morbidity and mortality associated with influenza infection. Proper management of patients includes: vaccination, monitoring for symptoms and isolation of potentially infected patients as well as appropriate antiviral therapies. In some cases of exposure, chemoprophylaxis is warranted. Vaccination and appropriate therapies are associated with improved outcomes.
[h=4]KEYWORDS:[/h] Chemoprophylaxis; End-stage renal disease; Influenza; Vaccination
PMID: 28528400 DOI: 10.1007/s40620-017-0407-9